ArticleEpilepsia2026
Assessment of the utility of optically pumped magnetometer magnetoencephalography in preoperative localization of refractory epilepsy: A prospective study.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
objectivePrecise localization of the epileptogenic zone (EZ) is crucial for epilepsy surgery success. Optically pumped magnetometer magnetoencephalography (OPM-MEG) is a promising noninvasive technique requiring rigorous clinical validation.
methodsIn this prospective diagnostic study, 68 patients with refractory epilepsy underwent 90-min interictal OPM-MEG. Dipoles were fitted to interictal epileptiform discharges for localization. The primary objective was to evaluate the spatial concordance between OPM-MEG and the EZ defined by intracranial electroencephalography (iEEG; stereo-EEG or electrocorticography), assessed at the sublobar level using Gwet AC1. The secondary objective was to evaluate the diagnostic value of OPM-MEG for surgical outcome. This analysis included 51 patients who underwent curative intervention (resection or thermocoagulation). The reference standard was a composite of the treated brain region and seizure freedom (International League Against Epilepsy [ILAE] class 1 or Engel class I) at ≥12-month follow-up, from which sensitivity, specificity, and diagnostic odds ratio (OR) were calculated.
resultsOPM-MEG showed almost perfect agreement with iEEG-based EZ localization overall (AC1 = .885, concordance rate = 90.0%), with substantial agreement in temporal (80.1%, AC1 = .723) and almost perfect agreement in extratemporal regions (92.0%, AC1 = .926). The Euclidean centroid distance between OPM-MEG and iEEG localizations was significantly shorter in concordant versus discordant cases. In the assessment of diagnostic value, OPM-MEG demonstrated a sensitivity of 85.7% and specificity of 65.2% (OR = 11.25) under ILAE criteria, and a sensitivity of 73.0% and specificity of 64.3% (OR = 4.86) under Engel criteria. SIGNIFICANCE: OPM-MEG demonstrates high concordance with iEEG for EZ localization and provides robust diagnostic value for predicting postoperative seizure freedom, supporting its utility in the presurgical evaluation of refractory epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.